256 related articles for article (PubMed ID: 28810297)
1. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
Wei MC; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
[No Abstract] [Full Text] [Related]
2. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
[TBL] [Abstract][Full Text] [Related]
3. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
[TBL] [Abstract][Full Text] [Related]
4. [Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
Lao I; Chen Q; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):364-9. PubMed ID: 25208984
[TBL] [Abstract][Full Text] [Related]
5. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
Piao ZH; Zhou XC; Chen JY
Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
Pavlisko EN; Roggli VL
Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
[TBL] [Abstract][Full Text] [Related]
7. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
8. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
9. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors.
Goldblum J; Hart WR
Am J Surg Pathol; 1995 Oct; 19(10):1124-37. PubMed ID: 7573671
[TBL] [Abstract][Full Text] [Related]
10. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
Cagle PT; Truong LD; Roggli VL; Greenberg SD
Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
[TBL] [Abstract][Full Text] [Related]
14. Pathohistological diagnosis and differential diagnosis.
Tischoff I; Neid M; Neumann V; Tannapfel A
Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
[TBL] [Abstract][Full Text] [Related]
15. A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
Hurtuk MG; Carbone M
Anticancer Res; 2004; 24(5B):3097-102. PubMed ID: 15510595
[TBL] [Abstract][Full Text] [Related]
16. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.
Yao DX; Shia J; Erlandson RA; Klimstra DS
Ultrastruct Pathol; 2004; 28(4):213-28. PubMed ID: 15693633
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma with mesothelioma-like dissemination.
Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H
Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087
[TBL] [Abstract][Full Text] [Related]
18. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
Khalidi HS; Medeiros LJ; Battifora H
Am J Clin Pathol; 2000 May; 113(5):649-54. PubMed ID: 10800396
[TBL] [Abstract][Full Text] [Related]
19. [Peritoneal tumor pathology - case no 4: an aggressive peritoneal tumor].
Sabourin JC
Ann Pathol; 2015 Aug; 35(4):338-41. PubMed ID: 26189364
[No Abstract] [Full Text] [Related]
20. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
Klebe S; Mahar A; Henderson DW; Roggli VL
Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
